P. Hiemstra (Leiden, The Netherlands), H. Fehrenbach (Borstel, Germany)
Expression of muscarinic M5 receptors on tissue lymphocytes and alveolar macrophages in mild and severe COPD
M. Mori, C. Andersson, L. Bjermer, C. G. Löfdahl, J. Erjefält (Lund, Sweden)
|  |
Structural alterations in childhood asthma are not dependent on eosinophilic inflammation
S. Baraldo, G. Turato, E. Bazzan, S. Agostini, F. Polverino, K. Lokar-Oliani, B. Nordio, A. Ballarin, F. Calabrese, C. Panizzolo, A. Barbato, R. Zuin, M. Saetta (Padova, Cava de‘ Tirreni, Italy)
| |
Cigarette smoke significantly reduces proliferation and modulates the expression levels of CEBPα and CEBPβ in cultured human lung fibroblasts
N. Miglino, M. Roth, M. Tamm, P. Borger (Basel, Switzerland; Sydney, Australia)
|  |
Endogenous indoleamine 2,3-dioxygenase activity reduces local inflammatory cell numbers
K. van der Sluijs, K. van Gisbergen, R. Lutter (Amsterdam, Netherlands)
| |
Ultrastructure analysis of airway smooth muscle cells in fatal asthma
B. Araújo, E. Caldini, L. F. Silva, C. Seow, V. Peinado, M. Dolhnikoff, T. Mauad (Sao Paulo/Sao Paulo, Brazil; Vancouver, BC, Canada; Barcelona/Barcelona, Spain)
| |
Increased proportion of Fas positive T-cells in never smoking patients with COPD
J. Domagala-Kulawik, M. Dabrowska, G. Hoser, R. Rubinsztain, A. Doboszynska, R. Chazan (Warsaw, Poland)
| |
Similar sputum secretory leykocyte inhibitor and Clara cell protein 16 levels between current and ex-smokers with COPD
M. Tsoumakidou, I. Bouloukaki, N. Siafakas, N. Tzanakis (Heraklion, Greece)
| |
Remodeling of lymphatics in the airway walls of fatal asthmatics
M. Ebina (Sendai/Miyagi, Japan)
| |
Tc2 response at the onset of COPD exacerbations
S. Lazarou, D. Makris, M. Alexandrakis, T. Kourelis, K. Bartziokas, D. Kyriakou, K. Gourgoulianis (Larissa, Crete, Greece)
| |
Angiogenesis in bronchial biopsies of symptomatic smokers with and without lung cancer
C. Calabrese, I. Pedicelli, A. Vatrella, C. Guarino, V. Bocchino, C. Tranfa, C. Turino, S. Marsico (Naples, Italy)
| |
In vitro effect of TGF-beta1 and IL4 on human bronchial fibroblasts phenotype
C. Bunu, G. Tanasie, C. A. Tatu, B. Matis, C. Tatu, V. Paunescu (Timisoara, Romania)
| |
Treatment of COPD exacerbations is able to influence the mononuclear cells level of the peripheral blood
L. Postnikova, N. Kubysheva, V. Novikov, R. Mindubaev, M. Boldina (Nnizhny Novgorod, Rwanda)
| |
Diesel exhaust particles-induced changes in cell viability of human lung epithelial cells may be associated with inflammatory cytokine release
H. Bayram, B. Gogebakan, O. Dikensoy, E. Ekinci (Gaziantep, Turkey)
| |
Is soluble MICA facilitating tumor immune evasion in patients with COPD?
M. Orozco-Levi, A. Sanchez-Font, C. Coronell, A. Ramirez-Sarmiento, J. Gea, V. Curull (Barcelona, Spain)
| |
The PDE4 inhibitor roflumilast N-oxide partly restored cigarette smoke (CS)-induced tight junction disassembly in human airway epithelial cells (Calu-3) – role of MAPK
L. Petecchia, C. Usai, L. Varesio, S. De Flora, A. Camoirano, G. A. Rossi (Genoa, Italy)
| |
MAP kinase phosphatase 1 mediates glucocorticoid inhibition of CD38 expression in human airway smooth muscle
J. Jude, B. N. Kang, T. Walseth, M. Kannan (Saint Paul, MN, Minneapolis, MN, United States Of America)
| |
Airway epithelium, lymphocyte, neutrophil and macrophage apoptosis in chronic obstructive pulmonary disease
A. Kocabas, S. Sabanci Kücükaltun, A. Uguz, S. Erdogan, G. Seydaoglu (Balcali, Adana, Turkey)
| |
Increased expression of Smads in vernal keratocongiuntivitis. A comparison with asthma
P. Brun, R. Benetti, I. Gnemmi, M. Carbone, C. Vicari, G. Abatangelo, A. Di Stefano, A. Leonardi (Padova, Padua, Veruno (NO), Italy)
| |
Study of MUC5AC, IL-8 and TNF-a gene expression in bronchial epithelial cells of healthy smokers after exposition to cigarette smoke extract
A. De Diego, B. Bedrina, J. Cortijo, M. Leon, L. Compte, E. Morcillo (Valencia, Spain)
| |
LDH levels in chronic cough patients
H. Fathi, V. Mann, R. Wilmot, A. Morice (Cottingham, Hull, United Kingdom)
| |